Centrul Medical Perseide S.R.L.
- Address
- Soseaua Bucuresti Urziceni 193, 077010 Afumati, Romania
Centrul Medical Perseide S.R.L.
Centrul Medical Perseide S.R.L. is a clinical research center dedicated to advancing treatments for complex systemic and cardiovascular conditions. The center demonstrates expertise in conducting multinational Phase 3 clinical trials, focusing on novel therapeutic approaches for autoimmune disorders and cardiovascular disease prevention. Their research portfolio reflects a commitment to evaluating innovative biologic therapies and preventive interventions that address significant unmet medical needs.
- Autoimmune disorders, particularly systemic lupus erythematosus (SLE) treatment with targeted biologic agents
- Primary prevention of atherosclerotic cardiovascular disease in high-risk patient populations
- Novel lipid-lowering therapies for reducing major adverse cardiovascular events
The center's research activities emphasize both immunological interventions for chronic inflammatory conditions and cardiovascular risk reduction strategies. By participating in pivotal trials evaluating treatments such as ianalumab for lupus and inclisiran for cardiovascular disease prevention, Centrul Medical Perseide contributes to developing evidence-based therapies that may transform patient outcomes in these challenging therapeutic areas. Their involvement in placebo-controlled superiority studies demonstrates their capability in conducting rigorous clinical investigations aligned with international regulatory standards.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1AstraZeneca AB1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrul Medical Perseide S.R.L.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Balcinrenone and Dapagliflozin on Cardiovascular Outcomes in Heart Failure Patients with Renal Impairment: A Phase III Randomized, Double-Blind Study | AstraZeneca AB | Phase III | Recruiting | Jul 2024 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Inclisiran | 2 | Unknown | 2023-09-04 | 2023-09-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.